CONCLUSIONS	This randomized , double-blind , placebo-controlled trial demonstrates that repeated-dose terutroban for 15 days improves endothelial function and inhibits thromboxane A ( 2 ) - induced platelet aggregation in high-cardiovascular-risk patients taking 300 mg of aspirin per day .\